Denosumab for Type 1 Diabetes | MicrobiomeTrials← Back to trialsNCT06524960
Denosumab for Type 1 Diabetes
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2025-05-05Est. Completion: 2027-10-11
Enrollment target: 45 participants Locations- University of Alabama at Birmingham, Birmingham, Alabama, United States
- City of Hope Medical Center, Duarte, California, United States
- Indiana University, Indianapolis, Indiana, United States
Other microbiome trials you might be interested in
Type 1 Diabetes
This is a prospective, non-randomized, observational cohort study conducted in adult patients with type 1 diabetes.Parti…
Athens, GreeceEst. completion Sep 1, 2022
Type 2 DiabetesHealhty
This study investigates how the naturally occurring gut hormones GIP and GLP-1 influence whole-body glucose uptake and o…
Copenhagen, DenmarkEst. completion Mar 12, 2027
Completed
Chronic Kidney DiseaseType 1 Diabetes Mellitus
Researchers are looking for a better way to treat people with chronic kidney disease (CKD), a progressive decrease in th…
Surprise, United StatesCompleted Aug 20, 2025